WITH World Antimicrobial Resistance Awareness Week on, the International Pharmaceutical Federation (FIP) today issued a new statement of policy on mitigating Anti-Microbial Resistance (AMR).
FIP stated that govts and policymakers, in collaboration with national pharmacy organisations, must regulate and monitor the consumption of antimicrobials, routes of access to them, and data availability about them in humans and animals.
The statement lists several further recommendations to this group of stakeholders, including that they take action to facilitate the registration of new or existing antimicrobials, provide appropriate economic incentives to encourage their development and commercial availability, and to allow pharmacists to produce essential antibiotics in cases of shortage.
FIP Vice President Manjiri Gharat, who is also co-chair of the FIP Commission on AMR and who co-led the policy committee that developed the statement said, "this new policy replaces one published by FIP in 2017".
"It also makes a strong call on pharmacists to embrace leadership roles in mitigating AMR and advancing antimicrobial stewardship," she added.
"In addition, the statement calls on pharmacists to encourage the use of point-of-care diagnostic tools to screen for early signs of infectious diseases, as well as to advocate for an environmentally conscious approach and the application of green pharmacy principles throughout the life cycle of antibiotics," Gharat remarked. JG
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Nov 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Nov 23
